期刊文献+

老视矫正药物及手术的研究进展

Research Progress of Drugs and Surgery for Presbyopia Corrective
原文传递
导出
摘要 老视是一个全球性的问题,不仅会影响患者的生活质量,甚至会增加从事工作和生活所必需活动时的安全性风险。老视是老化导致的晶状体光学功能障碍或晶状体功能失调综合征的早期表现,在晶状体功能失调综合征的3个阶段,适宜的矫正方式也有所不同。老视矫正的方法有很多,以框架眼镜和隐形眼镜较为多见。随着数字化需求的增加,人们对调节能力的依赖程度以及脱镜需求越来越高,因此老视的药物治疗、角膜、巩膜和晶状体手术的进展具有重大意义。现笔者对可获得的以及正在研究的老视矫正药物和手术进行综述,并对老视未来的治疗方法进行讨论。 Presbyopia is a global issue that not only impacts the quality of life for individuals but also escalates safety risks associated with necessary occupational and daily activities.The condition of presbyopia arises from age-related dysfunction of the crystalline lens or represents the earliest stage of dysfunctional lens syndrome.Different stages within this dysfunction syndrome need distinct methods for appropriate correction.Various approaches are available for presbyopia correction,with spectacles and contact lenses being commonly employed.However,due to increasing digital demands,there is a growing reliance on adaptive capabilities and a need for spectacle independence.Therefore,advancements in pharmacological therapies for presbyopia as well as corneal,scleral,and lenticular procedures hold significant importance.The author provides an overview of pharmacological therapies and procedures available and under investigation for presbyopia correction and discusses future treatments for presbyopia.
作者 黄怡芳 孙靖 Yifang Huang;Jing Sun(Tianjin Key Laboratory of Retinal Functions and Diseases,Tianjin Branch of National Clinical Research Center for Ocular Disease,Eye Institute and School of Optometry,Tianjin Medical University Eye Hospital,Tianjin 300384,China)
出处 《中华眼视光学与视觉科学杂志》 CAS CSCD 北大核心 2024年第3期231-235,共5页 Chinese Journal Of Optometry Ophthalmology And Visual Science
关键词 老视 晶状体功能失调综合征 药物治疗 屈光性晶状体置换 角膜手术 巩膜手术 presbyopia dysfunctional lens syndrome pharmacological therapies refractive lens exchange corneal procedures scleral procedures
  • 相关文献

参考文献4

二级参考文献22

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部